Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions

Обзор

The vast majority of cardiac rehabilitation eligible individuals do not participate in center based cardiac rehabilitation (CBCR). While steps to encourage participation in CBCR are important, many individuals will still not participate for a variety of reasons. This randomized controlled trial is evaluating a home-based cardiac rehabilitation (HBCR) intervention delivered using a custom app and digital tools in patients undergoing transcatheter heart valve interventions (THVIs). After a brief roll-in period, participants not intending to participate in CBCR are randomized to one of three groups: (1) control, (2) HBCR mobile health intervention with hands-off delivery, and (3) HBCR mobile health intervention with interactive delivery. Participants in the intervention groups (hands-off/interactive delivery) will also be randomized to continue the intervention for 12 weeks or 24 weeks. The intervention targets key health behaviors and includes traditional cardiac rehabilitation components. The study will assess the effect of the intervention on clinical events, physical activity, quality of life, and other outcomes. Those who intend to participate in CBCR will be followed in a registry.

Вмешательства

• Другое HBCR hands-off
  Home-based cardiac rehabilitation intervention facilitated by a custom app to deliver education, counseling on healthy living and modification of risk factors, mindfulness, and physical activity guidance.
• Другое HBCR interactive
  Home-based cardiac rehabilitation intervention facilitated by a custom app to deliver education, counseling on healthy living and modification of risk factors, mindfulness, and physical activity guidance. Additionally, there are periodic video calls with an exercise physiologist.

Первичные конечные точки

• Probability of the hierarchical clinical event composite [Срок оценки: Over the entire available follow-up period for randomized participants (minimum of 6 months, maximum approximately 24-30 months).]
• Average daily total activity counts [Срок оценки: The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily total activity counts determined. The primary comparison will be at 12 weeks after randomization.]

Вторичные конечные точки (12)

• Average daily total activity counts [Срок оценки: The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily total activity counts determined. The secondary comparisons will be at 24 and 52 weeks after randomization.]
• Average daily active minutes [Срок оценки: The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily active minutes determined. The comparisons will be at 12, 24 and 52 weeks after randomization.]
• Average daily steps [Срок оценки: The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily steps determined. The comparisons will be at 12, 24 and 52 weeks after randomization.]
• Average daily energy expenditure [Срок оценки: The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily energy expenditure determined. The comparisons will be at 12, 24 and 52 weeks after randomization.]
• Average daily moderate to vigorous active minutes [Срок оценки: The actigraphy device will be worn for approximately one week and, using data from days when the device was worn >10 hours, the average daily moderate to vigorous active mins determined. The comparisons will be at 12, 24 and 52 weeks after randomization.]
• 6 minute walk distance [Срок оценки: The comparisons will be at 12, 24 and 52 weeks after randomization.]
• Chair sit to stand time [Срок оценки: The comparisons will be at 12, 24 and 52 weeks after randomization.]
• 5 meter gait speed [Срок оценки: The comparisons will be at 12, 24 and 52 weeks after randomization.]
• All-cause hospitalizations [Срок оценки: Over the entire available follow-up period for randomized participants (minimum of 6 months, maximum approximately 24-30 months).]
• All-cause death [Срок оценки: Over the entire available follow-up period for randomized participants (minimum of 6 months, maximum approximately 24-30 months).]
• Heart-failure specific health status assessed by the KCCQ [Срок оценки: The comparisons will be at 12, 24 and 52 weeks after randomization.]
• Physical health status assessed by the PROMIS 10 [Срок оценки: The comparisons will be at 12, 24 and 52 weeks after randomization.]

Критерии участия

Критерии включения

• Treated with a transcatheter heart valve intervention (e.g., transcatheter aortic valve implantation \[in the native valve or valve-in-valve\], mitral transcatheter edge-to-edge repair, mitral valve-in-valve) of the aortic, mitral, or tricuspid valve done via transfemoral access

Критерии исключения

• Unwilling or unable to provide informed consent
• Not adherent to wearing the ActiGraph activity tracker during the roll-in phase for a minimum of 4 (out of 7) compliant days (worn >10 hours/day)
• Planned participation in center based cardiac rehabilitation (CBCR)
• Transcatheter heart valve intervention done via any route other than a transfemoral approach
• Stroke during or immediately after the transcatheter heart valve intervention prior to randomization
• Placement of a pacemaker within 6 weeks prior to the transcatheter heart valve intervention or after the transcatheter heart valve intervention and prior to randomization
• Those who require a walker or who cannot get out of a chair/bed on their own and walk independently (use of a cane is acceptable)
• Physical or neuropsychiatric limitations that would prevent proficient use of the study tools and successful completion of the physical and quality of life assessments (e.g. blindness, dementia)
• Planned surgery within 6 months after the heart valve intervention
• Planned discharge from hospital to hospice, assisted living, or inpatient rehabilitation facility (discharge to a senior facility permitted as long as they are considered Independent Living)
• Treating provider or site PI indicates that participation in the study would be unsafe
• Participation in any ongoing randomized trial that has not completed follow-up unless the sponsor of the other trial allows enrollment of the participant in this cardiac rehabilitation trial
• Unable to complete the baseline study visit prior to 6 weeks after the transcatheter heart valve intervention

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Простое слепое

Основная цель

Лечение

Центры проведения

США · 1 центр

• Vanderbilt University Medical Center — Nashville

Идентификаторы

NCT: NCT06077201 · 222231 · 5R01AG073633-02

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗